Skip to main content
. 2008 Apr 16;2008(2):CD005589. doi: 10.1002/14651858.CD005589.pub2

4.1. Analysis.

Comparison 4: Topotecan versus Topotecan/thalidomide, Outcome 1: Progression free survival

Progression free survival
Study Group Median (month) 95% CI P value
Downs 2008 Topotecan 4 2.9 to 5.1  
Topotecan with thalidomide 6 4.2 to 7.7 0.02